Bavencio® (avelumab) – New orphan drug approval
March 23, 2017 – The FDA announced the approval of EMD Serono’s Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC).
Download PDF
